OVID · Ovid Therapeutics Inc.
$2.88
-0.03 (-1.03%)
At close · Aug 26
Market Cap
$564.41M
Shares
195.30M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2026-08-13 | 2026-08-11 | |
| 10-Q | 2026-08-13 | 2026-06-30 | |
| 8-K | 2026-07-08 | 2026-07-05 | |
| Investor Event Transcript | 2026-06-15 | 2026-06-30 | |
| 8-K | 2026-06-11 | — | |
| 8-K | 2026-06-03 | 2026-05-29 | |
| 10-Q | 2026-05-12 | 2026-03-31 | |
| 8-K | 2026-05-12 | — | |
| DEF 14A | 2026-04-27 | 2025-12-31 | |
| 8-K | 2026-04-20 | 2026-04-17 | |
| 10-K | 2026-03-18 | 2025-12-31 | |
| 8-K | 2026-03-18 | 2026-03-17 | |
| 8-K | 2025-12-18 | — | |
| 8-K | 2025-12-11 | — | |
| 8-K | 2025-11-12 | — | |
| 10-Q | 2025-11-12 | 2025-09-30 | |
| DEF 14A | 2025-11-07 | 2025-12-11 | |
| 8-K | 2025-10-03 | 2025-10-02 | |
| 8-K | 2025-09-16 | 2025-09-11 | |
| 8-K | 2025-08-13 | — | |
| 10-Q | 2025-08-13 | 2025-06-30 | |
| 8-K | 2025-07-10 | — | |
| 8-K | 2025-06-25 | — | |
| DEF 14A | 2025-05-22 | 2024-12-31 | |
| 10-Q | 2025-05-13 | 2025-03-31 | |
| 8-K | 2025-05-13 | — | |
| 8-K | 2025-05-02 | 2025-05-01 | |
| 10-K/A | 2025-04-30 | 2024-12-31 | |
| 8-K | 2025-03-11 | 2025-03-10 | |
| 10-K | 2025-03-11 | 2024-12-31 | |
| 8-K | 2025-03-05 | 2025-03-01 | |
| 8-K | 2025-02-13 | 2025-02-10 | |
| 10-Q | 2024-11-12 | 2024-09-30 | |
| 8-K | 2024-11-12 | — | |
| 8-K | 2024-09-11 | 2024-09-08 | |
| 10-Q | 2024-08-13 | 2024-06-30 | |
| 8-K | 2024-08-13 | — | |
| 8-K | 2024-08-02 | 2024-07-30 | |
| 8-K | 2024-07-01 | — | |
| 8-K | 2024-06-28 | 2024-06-27 | |
| 8-K | 2024-06-17 | — | |
| 8-K | 2024-06-07 | 2024-06-06 | |
| 8-K | 2024-05-14 | — | |
| 10-Q | 2024-05-14 | 2024-03-31 | |
| DEF 14A | 2024-04-24 | — | |
| 8-K | 2024-03-08 | — | |
| 10-K | 2024-03-08 | 2023-12-31 | |
| 8-K | 2023-12-06 | 2023-12-04 | |
| 10-Q | 2023-11-03 | 2023-09-30 | |
| 8-K | 2023-11-03 | — |
Showing 1–50 of 122 filings
Key facts
CIK
1636651
CUSIP
690469101
13F (30d)
126 filings
120 filers
Visit website
Investor relations